… ProQR to Present at Upcoming JMP Securities Life Sciences … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Eve n ts ”. The archived webcast will …
… ProQR to Present at Upcoming Scientific Meeting and Investor … at 9:30am EST, Daniel de Boer, Chief Executive Officer of ProQR, will present at the LEERINK 7 th Annual Global … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Announces Financial Results for the Third Quarter of … LCA10,” said Daniel A. de Boer, chief executive officer of ProQR. “These results build confidence in QR-110 and the … for QR-110 in patients with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: …
… ProQR Announces Financial Results for the Second Quarter of … said Daniel A. de Boer, chief executive officer of ProQR. “Over the next twelve months, we are looking forward … current cash on hand of €33.0 million (at June 30, 2018), ProQR’s operation is funded into late 2019 Subsequent Events …
